The molecular clock gene cryptochrome 1 (CRY1) and its role in cluster headache. (November 2021)

• Record Type: Journal Article
• Authors: Fourier, Carmen; Ran, Caroline; Sjöstrand, Christina; Waldenlind, Elisabet; Steinberg, Anna; Belin, Andrea Carmine
• Is Part Of: Cephalalgia. Volume 41:Number 13(2021)
• Page Start: 1374
• Page End: 1381
• Publication Date: 2021-11
• Subjects: circadian rhythm -- single nucleotide polymorphism -- mRNA expression -- case-control study -- genetic association study -- cluster headache genetics; Headache -- Periodicals; 616.8491
• DOI: 10.1177/03331024211024165
• Languages: English
• ISSNs: 0333-1024

Abstract

Background: Cluster headache is a severe primary headache disorder commonly featuring a strikingly distinct circadian attack pattern. Therefore, the circadian system has been suggested to play a crucial role in the pathophysiology of cluster headache. Cryptochromes are key components of the molecular clock generating circadian rhythms and have previously been shown to be associated with several psychiatric disorders, including seasonal affective disorder, bipolar disorder, and depression. Methods: In this case-control study, we investigated the role of cryptochrome ( CRY ) genes in cluster headache by screening 628 cluster headache patients and 681 controls from Sweden for four known genetic variants in the CRY1 (rs2287161 and rs8192440) and CRY2 (rs10838524 and rs1554338) genes. In addition, we analyzed CRY1 gene expression in primary fibroblast cell lines from eleven patients and ten controls. Results: The exonic CRY1 variant rs8192440 was associated with cluster headache on allelic level ( p =0.02) and this association was even more pronounced in a subgroup of patients with reported diurnal rhythmicity of attacks ( p =0.002). We found a small significant difference in CRY1 gene expression between cluster headache patients and control individuals ( p =0.04), but we could not identify an effect of the associated variant rs8192440 on CRY1 expression. Conclusions: We discovered a disease-associated variant in the CRY1 gene and slightly increased CRY1 gene expression in tissue from cluster headache patients, strengthening the hypothesis of circadian dysregulation in cluster headache. How this gene variant may contribute to the pathophysiology of the disease remains subject to further studies.